Yes, if terms a reasonable, we will re-rate rapidly. Starting to turn I feel, good to see some coal stocks that have doubled in price from lows like Whitehaven an Atrum. GL LT's
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%